Postherpetic Neuralgia News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

CDC touts new shingles vaccine as more than 90 percent effective - The Daily Progress



The Daily Progress
 
CDC touts new shingles vaccine as more than 90 percent effective 
The Daily Progress
And it can lead to complications, the most common of which is nerve pain, or post-herpetic neuralgia, which can be severe and debilitating. While it usually resolves in a few weeks or months, the CDC said, the pain can persist for years. Shingles also ...

 


Postherpetic Neuralgia Market Phase III Drugs Landscape, 2017 - Insider Tradings



Insider Tradings
 
Postherpetic Neuralgia Market Phase III Drugs Landscape, 2017 
Insider Tradings
Postherpetic Neuralgia-Mechanism of action Insights, 2017?, report provides comprehensive insights of the ongoing therapeutic research and development across Postherpetic Neuralgia. The report provides a complete understanding of the pipeline ...

and more » 


CDC touts new shingles vaccine as more than 90 percent effective; 'I'm very thrilled' this is available,' says ... - Omaha World-Herald



Omaha World-Herald
 
CDC touts new shingles vaccine as more than 90 percent effective; 'I'm very thrilled' this is available,' says ... 
Omaha World-Herald
And it can lead to complications, the most common of which is nerve pain, or post-herpetic neuralgia, which can be severe and debilitating. While it usually resolves in a few weeks or months, the CDC said, the pain can persist for years. Shingles also ...

and more » 


Should you get the new shingles vaccine? - MassLive.com



MassLive.com
 
Should you get the new shingles vaccine? 
MassLive.com
GlaxoSmithKline plans to begin shipping its new FDA-approved vaccine Shingrix this month. How big of a development is this new vaccine in your view and why? I think that the Shingrix vaccine is an improvement on Zostavax. It does appear to reduce the ...

 


Post Herpetic Neuralgia Treatment Market Expansion to be Persistent During 2017 ? 2025 - MilTech



Post Herpetic Neuralgia Treatment Market Expansion to be Persistent During 2017 ? 2025 
MilTech
Acute pain is caused due to an attack on shingles by varicella zoster virus, which usually stops when the shingles rash is cleared and it continues after cure this situation is named as post-herpetic neuralgia (PHN). The condition is more prone in the ...

 


A shingles survivor's advice to the middle-aged: Get the vaccine - Philly.com



Philly.com
 
A shingles survivor's advice to the middle-aged: Get the vaccine 
Philly.com
... drugs and oral corticosteroids ? may save days of pain and discomfort. Any suspicious rash on the face should be treated as soon as possible because of the risk of shingles attacking the eye or ear, advises Priya Sampathkumar, an infectious ...

and more » 


Shingles Vaccine Important for Older Adults - UKNow (press release)



UKNow (press release)
 
Shingles Vaccine Important for Older Adults 
UKNow (press release)
The shingles rash can be extremely painful and result in postherpetic neuralgia, which is pain that lasts even after the rash has resolved. Your risk for shingles increases significantly after the age of 50 and the Centers for Disease Control and ...

and more » 


New clinician resource available explains biological impact of aging on immunity - EurekAlert (press release)



New clinician resource available explains biological impact of aging on immunity 
EurekAlert (press release)
Vaccination is an important way of reducing risk of getting shingles and its complications, like postherpetic neuralgia (PHN) and necessity of prescribing pain relievers. "Shingles is an example of a disease that afflicts one million adults every year ...

and more » 


Is ContraVir Pharmaceuticals, Inc. (CTRV)'s Fuel Running Low? The Stock Reaches 52-Week Low Today - BZ Weekly



Is ContraVir Pharmaceuticals, Inc. (CTRV)'s Fuel Running Low? The Stock Reaches 52-Week Low Today 
BZ Weekly
ContraVir Pharmaceuticals, Inc. operates as a biopharmaceutical firm focused on the development of antiviral drugs with a primary emphasis on the treatment of Hepatitis B virus infections. The company has market cap of $28.81 million. The firm is ...

and more » 


Shingles Vaccine Important to Older Adults - SurfKY News (blog)



SurfKY News (blog)
 
Shingles Vaccine Important to Older Adults 
SurfKY News (blog)
The shingles rash can be extremely painful and result in postherpetic neuralgia, which is pain that lasts even after the rash has resolved. Your risk for shingles increases significantly after the age of 50 and the Centers for Disease Control and ...
GSK phase III study supports safety & efficacy of Shingrix in preventing shingles in auHSCT patients pharmabiz.com

all 4 news articles »